Frank Yocca - Net Worth and Insider Trading
Frank Yocca Net Worth
The estimated net worth of Frank Yocca is at least $18,805 dollars as of 2024-11-13. Frank Yocca is the Chief Scientific Officer of BioXcel Therapeutics Inc and owns about 28,278 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $18,805. Details can be seen in Frank Yocca's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank Yocca has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frank Yocca
Frank Yocca Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Yocca owns 1 companies in total, including BioXcel Therapeutics Inc (BTAI) .
Click here to see the complete history of Frank Yocca’s form 4 insider trades.
Insider Ownership Summary of Frank Yocca
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-10-03 | Chief Scientific Officer |
Frank Yocca Latest Holdings Summary
Frank Yocca currently owns a total of 1 stock. Frank Yocca owns 28,278 shares of BioXcel Therapeutics Inc (BTAI) as of October 3, 2024, with a value of $18,805.
Latest Holdings of Frank Yocca
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-10-03 | 28,278 | 0.67 | 18,805 |
Holding Weightings of Frank Yocca
Frank Yocca Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Yocca has made a total of 9 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 7,175 shares on October 3, 2024, which brought Frank Yocca around $3,946.
Insider Trading History of Frank Yocca
- 1
Frank Yocca Trading Performance
GuruFocus tracks the stock performance after each of Frank Yocca's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Yocca is 39.94%. GuruFocus also compares Frank Yocca's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Yocca within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Yocca's insider trading performs compared to the benchmark.
Performance of Frank Yocca
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.54 | | | | | |
| Relative Return to S&P 500(%) | -0.08 | | | | | |
Frank Yocca Ownership Network
Ownership Network List of Frank Yocca
Ownership Network Relation of Frank Yocca
Frank Yocca Owned Company Details
What does BioXcel Therapeutics Inc do?
Who are the key executives at BioXcel Therapeutics Inc?
Frank Yocca is the Chief Scientific Officer of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include CHIEF COMMERCIAL OFFICER Matthew T. Wiley , Chief Financial Officer Richard I Steinhart , and Chief Medical Officer Vincent O'neill .
BioXcel Therapeutics Inc (BTAI) Insider Trades Summary
Over the past 18 months, Frank Yocca made 4 insider transaction in BioXcel Therapeutics Inc (BTAI) with a net sale of 8,969. Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 1,503,378 shares made by Vimal Mehta , a net sale of 13,972 shares made by Richard I Steinhart , and a net sale of 10,366 shares made by Javier Rodriguez .
In summary, during the past 3 months, insiders sold 36,432 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 36,432 shares. During the past 18 months, 1,550,438 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,550,438 shares.
BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioXcel Therapeutics Inc Insider Transactions
Frank Yocca Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Yocca. You might contact Frank Yocca via mailing address: 780 East Main Street, C/o Bioxcel Therapeutics, Inc., Branford Ct 06405.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
